产品详情
Targets
Target | Value |
---|---|
C-Raf | IC50: 1.4nM |
B-Raf | IC50: 8.3nM |
AuroraB | IC50: 66nM |
PDGFRβ | IC50: 120nM |
FGFR3 | IC50: 280nM |
GSK-3β | IC50: 500nM |
CDK2 | IC50: 580nM |
p38α | IC50: 600nM |
PDGFRα | IC50: 610nM |
Tie-2 | IC50: 740nM |
CDK1 | IC50: 790nM |
Chk1 | IC50: 1.4μM |
MEK1 | IC50: 3.7μM |
IKKβ | IC50: 3.7μM |
PKA | IC50: >10μM |
PKCθ | IC50: >10μM |
CK1δ | IC50: >10μM |
ERK1 | IC50: >10μM |
EGFR | IC50: >10μM |
HER2 | IC50: >10μM |
JNK1 | IC50: >10μM |
c-Met | IC50: >10μM |
c-Kit | IC50: >10μM |
Src | IC50: >10μM |
IR | IC50: >10μM |
MEKK1 | IC50: >10μM |
In vitro (25°C) | DMSO | 99 mg/mL (178.53 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (3.6 mM) | ||
In vivo | 2% DMSO+98% PEG 300 | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.03 mL | 90.17 mL | 180.34 mL |
0.5 mM | 3.61 mL | 18.03 mL | 36.07 mL |
1 mM | 1.8 mL | 9.02 mL | 18.03 mL |
5 mM | 0.36 mL | 1.8 mL | 3.61 mL |
*The above data is based on the productmolecular weight 554.51. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A13323 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 554.51 |
Formula | C27H18F4N4O3S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1228591-30-7 |
Synonyms | TAK 632; TAK632 |
SMILES | C1CC1C(=O)NC2=NC3=C(S2)C(=C(C=C3)OC4=CC(=C(C=C4)F)NC(=O)CC5=CC(=CC=C5)C(F)(F)F)C#N |
产品标签
Product Questions
Product Questions
Diazepinomicin
Diazepinomicin,也称为TLN-4601,是具有潜在抗肿瘤活性的RAS/RAF/MAPK信号传导途径的小分子抑制剂。
B-Raf-inhibitor 1
B-Raf inhibitor 1是有效的选择性B-Raf抑制剂,对A375增殖和A375 p-ERK的细胞IC50分别为0.31 uM和2 nM。
MLN2480 (BIIB-024)
MLN2480 (BIIB-024)是一种口服的Raf激酶抑制剂。
RAF265 (CHIR-265)
RAF265 (CHIR-265)是一种口服,高度选择性的RAF和VEGFR激酶抑制剂,可控制或正常化VEGFR-2,同时抑制B-raf和c-Raf…
RO5126766 (CH5126766)
RO5126766 (CH5126766)是对Raf和MEK丝裂原激活的蛋白激酶(MAPK)具有特异性的蛋白激酶抑制剂,具有潜在的抗肿…
Dabrafenib (GSK2118436A)
Dabrafenib (GSK2118436A)是一种有效且选择性的B-RAF蛋白激酶抑制剂,具有V600E突变,目前正在临床试验中。